Genpact LTD Form 4 insider transactions

NYSE
Genpact's Senior Vice President and CHRO, Piyush Mehta, executed a series of stock transactions involving the acquisition and sale of common shares and the exercise of employee stock options.
NYSE
Genpact director N.V. Tyagarajan sold 2,000 common shares at $46.7 each on November 12, 2024, while still holding a significant number of shares directly and indirectly.
NYSE
Genpact director Carol Lindstrom sold 3,218 common shares at a weighted average price of $46.5741 per share on November 12, 2024.
NYSE
Donald J. Klunk, Chief Accounting Officer of Genpact, reports the acquisition of 5,163 common shares and adjustments to holdings under the Employee Stock Purchase Plan.
NYSE
Balkrishan Kalra, President and CEO of Genpact, sold 7,000 common shares of the company on September 12, 2024, at an average price of $38.5409.
NYSE
Donald J. Klunk, Chief Accounting Officer of Genpact LTD, reported the sale of 800 common shares at $37.5042 on August 14, 2024, and an update on shares acquired through the Employee Stock Purchase Plan.
NYSE
Director N. V. Tyagarajan reported a transaction involving Genpact LTD shares on June 5, 2024.
NYSE
Director Tamara Franklin reports acquisition of restricted share units and disposal of common shares in Genpact LTD.
NYSE
Director N. V. Tyagarajan reports acquisition of restricted share units and disposition of shares held in trust.
NYSE
Director Ajay Agrawal reports acquisition of restricted share units and a decrease in common shares owned in Genpact LTD.
NYSE
Director CeCelia Morken reports acquisition of 6,707 restricted share units (RSUs) in Genpact LTD on May 2, 2024.
NYSE
Director Carol Lindstrom reports acquisition of restricted share units and a decrease in common shares owned in a recent Form 4 filing.
NYSE
Director Mark A. Verdi of Genpact LTD was granted 6,707 restricted share units on May 2, 2024, according to a recent SEC filing.
NYSE
Director Laura Conigliaro reports the acquisition of 6,707 restricted share units (RSUs) and changes in beneficial ownership of Genpact LTD shares.
NYSE
Director James C. Madden reports the acquisition of 10,539 restricted share units (RSUs) in Genpact LTD.
NYSE
Brian Mark Stevens, a director at Genpact LTD, reported the acquisition of 6,707 common shares and disposal of 25,273 common shares on May 2, 2024, according to a Form 4 filing.
NYSE
Donald J. Klunk, Chief Accounting Officer of Genpact, reports acquisition of shares through restricted stock units and the employee stock purchase plan.
NYSE
Senior Vice President Sameer Dewan reports acquisition of restricted share units and disposal of common shares.
NYSE
Heather White, SVP & Chief Legal Officer of Genpact, reports the acquisition of 41,284 restricted share units and disposition of 208 common shares acquired under the Genpact Employee Stock Purchase Plan.
NYSE
Senior Vice President and CHRO of Genpact, Piyush Mehta, reports acquisition of restricted share units and shares under the employee stock purchase plan, as well as disposal of shares.
NYSE
Genpact's CFO, Michael Hal Weiner, reports the acquisition of restricted share units and shares under the employee stock purchase plan.
NYSE
Senior Vice President Anil Nanduru reports acquisition of restricted share units and disposition of common shares.
NYSE
Senior Vice President Riju Vashisht reports acquisition of restricted share units and disposal of common shares in Genpact LTD.
NYSE
Genpact's CEO, Balkrishan Kalra, reports the acquisition of restricted share units and shares through the employee stock purchase plan.